7-Bromo-1H-quinoxalin-2-one, 95.0%, 25g

6-Fluorochromane-2-carboxylic acid, 97.0%, 25g

Methyl 2-amino-5-chloronicotinate, 95.0%, 25g

N-(5-(p-Tolyl)-1,3,4-thiadiazol-2-yl)benzamide, 95%, 25mg

(2S,3S)-3-Hydroxy-2-(4-methoxyphenyl)-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one, 95.0%, 10g

Seringue microlitre GASTIGHT® série 1700 Point type 3, 10 µl, 1701 RNR, 1 pièce

4'-Fluoro-4-hydroxy[1,1'-biphenyl]-3-carbaldehyde, 96.0%, 1g

2-Amino-5-chloro-3-iodobenzonitrile, 95.0%, 5g

Methyl 2-methoxypyrimidine-5-carboxylate, 97%, 100mg

methyl 2-methyl-3-{[(pyridin-2-yl)methyl]amino}propanoate, 95.0%, 10g

2-({[(3-methylphenyl)carbamoyl]methyl}sulfanyl)acetic acid, 97%, 250mg

Tert-butyl 4-(4-aminophenoxy)-3,3-difluoropiperidine-1-carboxylate, 98%, 1g

4-(4-Bromo-1H-pyrazol-1-yl)piperidine hydrochloride, 97%, 1g